Dr. Marjan Farid, MD

Dr. Farid practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Farid's NPI, 1275589756, was assigned on May 26, 2006. Dr. Farid graduated from UC San Diego School of Medicine in 2002. Dr. Farid holds California license A85936.

Dr. Farid's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Farid's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dmand AI also links Dr. Farid to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farid practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Farid's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Farid is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Farid is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Farid treats.

CMS data shows 3,226 Medicare services from Dr. Farid across 13 procedure codes in 2024, for 1,036 Medicare patients. Medicare paid $387,562 for them.

CMS counts 1,036 Medicare patients who saw Dr. Farid in 2024. The largest group is 75 to 84, with 485 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farid's median patient age at 73, with 58% women.

In 2024, Dr. Farid wrote 1,548 Medicare Part D claims for 446 patients. 41% of them were for generic drugs. CMS names the drug for 1,430 of them, across 26 drugs with 11 or more claims each, at $338,589 in total drug cost. In 2023, CMS named 1,768 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Farid for performance year 2024, reported through an alternative payment model (APM). Dr. Farid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 575 procedures of cataract surgery by Dr. Farid, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 69 papers to Dr. Farid, published from 2008 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Cornea, Keratoplasty, Penetrating and Visual Acuity. Dr. Farid has published most often in Cornea. Dr. Farid's most frequent co-authors are Sumit Garg, MD, Preeya Kshettry Gupta, MD and Brandon Daniel Ayres, MD.

CMS Open Payments shows 756 general payments to Dr. Farid from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $326,783. It also lists 1 research payment totaling $7,800 in 2021.

Dmand AI lists 29 awards for Dr. Farid, most recently Regional Top Doctor in 2014.

Dr. Farid graduated from UC San Diego School of Medicine in 2002. Dr. Farid is a member of AAO, AECOS, ASCRS, ASCRS Cornea Clinical Committee, ARVO and CMA.

Dr. Farid is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.